Literature DB >> 33091963

Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.

Pedro Melo1, Ektoras X Georgiou1, Neil Johnson2, Sabine F van Voorst3, Annika Strandell4, Ben Willem J Mol5, Christian Becker6, Ingrid E Granne6.   

Abstract

BACKGROUND: Tubal disease accounts for 20% of infertility cases. Hydrosalpinx, caused by distal tubal occlusion leading to fluid accumulation in the tube(s), is a particularly severe form of tubal disease negatively affecting the outcomes of assisted reproductive technology (ART). It is thought that tubal surgery may improve the outcome of ART in women with hydrosalpinges.
OBJECTIVES: To assess the effectiveness and safety of tubal surgery in women with hydrosalpinges prior to undergoing conventional in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI). SEARCH
METHODS: We searched the Cochrane Gynaecology and Fertility (CGF) Group trials register, CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL, DARE, and two trial registers on 8 January 2020, together with reference checking and contact with study authors and experts in the field to identify additional trials. SELECTION CRITERIA: Randomised controlled trials (RCTs) comparing surgical treatment versus no surgical treatment, or comparing surgical interventions head-to-head, in women with tubal disease prior to undergoing IVF. DATA COLLECTION AND ANALYSIS: We used Cochrane's standard methodological procedures. The primary outcomes were live birth rate (LBR) and surgical complication rate per woman randomised. Secondary outcomes included clinical, multiple and ectopic pregnancy rates, miscarriage rates and mean numbers of oocytes retrieved and of embryos obtained. MAIN
RESULTS: We included 11 parallel-design RCTs, involving a total of 1386 participants. The included trials compared different types of tubal surgery (salpingectomy, tubal occlusion or transvaginal aspiration of hydrosalpingeal fluid) to no tubal surgery, or individual interventions to one another. We assessed no studies as being at low risk of bias across all domains, with the main limitations being lack of blinding, wide confidence intervals and low event and sample sizes. We used GRADE methodology to rate the quality of the evidence. Apart from one moderate-quality result in one review comparison, the evidence provided by these 11 trials ranged between very low- to low-quality. Salpingectomy versus no tubal surgery No included study reported on LBR for this comparison. We are uncertain of the effect of salpingectomy on surgical complications such as the rate of conversion to laparotomy (Peto odds ratio (OR) 5.80, 95% confidence interval (CI) 0.11 to 303.69; one RCT; n = 204; very low-quality evidence) and pelvic infection (Peto OR 5.80, 95% CI 0.11 to 303.69; one RCT; n = 204; very low-quality evidence). Salpingectomy probably increases clinical pregnancy rate (CPR) versus no surgery (risk ratio (RR) 2.02, 95% CI 1.44 to 2.82; four RCTs; n = 455; I2 = 42.5%; moderate-quality evidence). This suggests that in women with a CPR of approximately 19% without tubal surgery, the rate with salpingectomy lies between 27% and 52%. Proximal tubal occlusion versus no surgery No study reported on LBR and surgical complication rate for this comparison. Tubal occlusion may increase CPR compared to no tubal surgery (RR 3.21, 95% CI 1.72 to 5.99; two RCTs; n = 209; I2 = 0%; low-quality evidence). This suggests that with a CPR of approximately 12% without tubal surgery, the rate with tubal occlusion lies between 21% and 74%. Transvaginal aspiration of hydrosalpingeal fluid versus no surgery No study reported on LBR for this comparison, and there was insufficient evidence to identify a difference in surgical complication rate between groups (Peto OR not estimable; one RCT; n = 176). We are uncertain whether transvaginal aspiration of hydrosalpingeal fluid increases CPR compared to no tubal surgery (RR 1.67, 95% CI 1.10 to 2.55; three RCTs; n = 311; I2 = 0%; very low-quality evidence). Laparoscopic proximal tubal occlusion versus laparoscopic salpingectomy We are uncertain of the effect of laparoscopic proximal tubal occlusion versus laparoscopic salpingectomy on LBR (RR 1.21, 95% CI 0.76 to 1.95; one RCT; n = 165; very low-quality evidence) and CPR (RR 0.81, 95% CI 0.62 to 1.07; three RCTs; n = 347; I2 = 77%; very low-quality evidence). No study reported on surgical complication rate for this comparison. Transvaginal aspiration of hydrosalpingeal fluid versus laparoscopic salpingectomy No study reported on LBR for this comparison, and there was insufficient evidence to identify a difference in surgical complication rate between groups (Peto OR not estimable; one RCT; n = 160). We are uncertain of the effect of transvaginal aspiration of hydrosalpingeal fluid versus laparoscopic salpingectomy on CPR (RR 0.69, 95% CI 0.44 to 1.07; one RCT; n = 160; very low-quality evidence). AUTHORS'
CONCLUSIONS: We found moderate-quality evidence that salpingectomy prior to ART probably increases the CPR compared to no surgery in women with hydrosalpinges. When comparing tubal occlusion to no intervention, we found that tubal occlusion may increase CPR, although the evidence was of low quality. We found insufficient evidence of any effect on procedure- or pregnancy-related adverse events when comparing tubal surgery to no intervention. Importantly, none of the studies reported on long term fertility outcomes. Further high-quality trials are required to definitely determine the impact of tubal surgery on IVF and pregnancy outcomes of women with hydrosalpinges, particularly for LBR and surgical complications; and to investigate the relative efficacy and safety of the different surgical modalities in the treatment of hydrosalpinges prior to ART.
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 33091963      PMCID: PMC8094448          DOI: 10.1002/14651858.CD002125.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  54 in total

1.  Ultrasound-guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: a randomized controlled trial.

Authors:  Nahed Hammadieh; Arri Coomarasamy; Bolarinde Ola; Spyros Papaioannou; Masoud Afnan; Khaldoun Sharif
Journal:  Hum Reprod       Date:  2008-03-13       Impact factor: 6.918

2.  Is removal of hydrosalpinges prior to in vitro fertilization the standard of care?

Authors:  Bradley J Van Voorhis; Rachel B Mejia; William D Schlaff; Bradley S Hurst
Journal:  Fertil Steril       Date:  2019-04       Impact factor: 7.329

3.  The mechanism of hydrosalpinx in embryo implantation.

Authors:  O Eytan; F Azem; I Gull; I Wolman; D Elad; A J Jaffa
Journal:  Hum Reprod       Date:  2001-12       Impact factor: 6.918

4.  Hydrosalpinges in in-vitro fertilization: an unfavourable prognostic feature.

Authors:  J Vandromme; E Chasse; B Lejeune; M Van Rysselberge; A Delvigne; F Leroy
Journal:  Hum Reprod       Date:  1995-03       Impact factor: 6.918

5.  [Effect of salpingectomy on the results of IVF in women with tubal sterility--prospective study].

Authors:  T Mardesić; P Muller; R Huttelová; J Zvárová; J Hulvert; J Voboril; V Becvárová; M Miková; K Landová; M Jirkovský
Journal:  Ceska Gynekol       Date:  2001-07

6.  Hydrosalpinx and IVF outcome: cumulative results after salpingectomy in a randomized controlled trial.

Authors:  A Strandell; A Lindhard; U Waldenström; J Thorburn
Journal:  Hum Reprod       Date:  2001-11       Impact factor: 6.918

7.  Hydrosalpinges adversely affect markers of endometrial receptivity.

Authors:  W R Meyer; A J Castelbaum; S Somkuti; A W Sagoskin; M Doyle; J E Harris; B A Lessey
Journal:  Hum Reprod       Date:  1997-07       Impact factor: 6.918

8.  Reduced pregnancy outcome in patients with unilateral or bilateral hydrosalpinx after in vitro fertilization.

Authors:  M Kassabji; J A Sims; L Butler; S J Muasher
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1994-08       Impact factor: 2.435

9.  Effect of salpingectomy on ovarian response to superovulation in an in vitro fertilization-embryo transfer program.

Authors:  A Lass; A Ellenbogen; C Croucher; G Trew; R Margara; C Becattini; R M Winston
Journal:  Fertil Steril       Date:  1998-12       Impact factor: 7.329

10.  [Effects of Tansvaginal Aspiration of Hydrosalpinx Combined Auricular Point Sticking on IVF-ET Outcomes].

Authors:  Jin-xia An; Ya-li Ni; Xiao-ling Liu; Xi-hong Gao; Yan Wang
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2015-06
View more
  5 in total

1.  ART Outcomes After Hysteroscopic Proximal Tubal Occlusion Versus Laparoscopic Salpingectomy for Hydrosalpinx Management in Endometriosis Patients.

Authors:  Chloé Maignien; Mathilde Bourdon; Juan Pablo Scarano-Pereira; Alessandro Martinino; Meryam Cheloufi; Louis Marcellin; Charles Chapron; Pietro Santulli
Journal:  Reprod Sci       Date:  2021-10-12       Impact factor: 3.060

2.  Prior salpingectomy impairs the retrieved oocyte number in in vitro fertilization cycles of women under 35 years old without optimal ovarian reserve.

Authors:  Cheng-Yu Ho; Yu-Yuan Chang; Yu-Hung Lin; Mei-Jou Chen
Journal:  PLoS One       Date:  2022-05-04       Impact factor: 3.240

3.  Predicting cumulative live birth for couples beginning their second complete cycle of in vitro fertilization treatment.

Authors:  Mariam B Ratna; Siladitya Bhattacharya; N van Geloven; David J McLernon
Journal:  Hum Reprod       Date:  2022-08-25       Impact factor: 6.353

Review 4.  Evidence and consensus on technical aspects of embryo transfer.

Authors:  Arianna D'Angelo; Costas Panayotidis; Alessandra Alteri; Saria Mcheik; Zdravka Veleva
Journal:  Hum Reprod Open       Date:  2022-09-06

Review 5.  Diagnosis and Management of Infertility: A Review.

Authors:  Sandra Ann Carson; Amanda N Kallen
Journal:  JAMA       Date:  2021-07-06       Impact factor: 157.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.